Watching West Pharmaceutical Services, Inc.? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planFunding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Back to SEC FilingsAcquisition/DispositionItem 2.01 · 8-KLOW RiskNeutral
West Pharmaceutical Services, Inc.
westpharma.comFiled: Jul 23, 2026Exton, PennsylvaniaCIK: 0000105770Health Care
AI Executive Summary
AI-powered analysis of 8-K filing content
West Pharmaceutical Services announced Q2 2026 financial results on July 23, 2026, providing investors with updated operational performance metrics and market position insights.
Key Takeaways
Company released second-quarter 2026 financial results including quarterly revenue and earnings figures
Press release and presentation materials were made available to investors and stakeholders
1 more takeaway
Related Filings (1)
1 more filing from West Pharmaceutical Services, Inc. in the last 90 days
Filing Overview
Form Type8-K
Filing DateJul 23, 2026
Item2.01
CategoryAcquisition/Disposition
CIK0000105770
Accession #wst-20260723
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
earnings
What This Means
The company completed a major acquisition or sold off a significant asset. This reshapes the company's portfolio and strategic direction.